AVITA Medical (ASX:AVH) Cyclically Adjusted PS Ratio: (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:AVH AVITA Medical Inc ASX:AVH
52 GF Score
Price A$1.54
GF Value A$2.89
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is AVITA Medical Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


AVITA Medical  (ASX:AVH) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


AVITA Medical Cyclically Adjusted PS Ratio Related Terms


AVITA Medical Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for AVITA Medical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AVITA Medical Cyclically Adjusted PS Ratio Chart

AVITA Medical Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.08 5.47 9.73 7.81 1.89

AVITA Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.99 2.83 1.89 1.97 0.00

ASX:AVH vs OWLT, CVRX, STIM: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, AVITA Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AVITA Medical Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AVITA Medical's Cyclically Adjusted PS Ratio falls into.


ASX:AVH
52GF Score
AVITA Medical Inc ASX:AVH
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AVITA Medical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

AVITA Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, AVITA Medical's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.201/333.9520*333.9520
=0.201

Current CPI (Jun. 2026) = 333.9520.

AVITA Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 0.000 246.819 0.000
201712 0.000 246.524 0.000
201803 0.000 249.554 0.000
201806 0.000 251.989 0.000
201809 0.000 252.439 0.000
201812 0.000 251.233 0.000
201903 0.000 254.202 0.000
201906 0.000 256.143 0.000
201909 0.051 256.759 0.066
201912 0.048 256.974 0.062
202003 0.059 258.115 0.076
202006 0.053 257.797 0.069
202009 0.065 260.280 0.083
202012 0.063 260.474 0.081
202103 0.100 264.877 0.126
202106 0.108 271.696 0.133
202109 0.077 274.310 0.094
202112 0.078 278.802 0.093
202203 0.082 287.504 0.095
202206 0.095 296.311 0.107
202209 0.109 296.808 0.123
202212 0.112 296.797 0.126
202303 0.125 301.836 0.138
202306 0.139 305.109 0.152
202309 0.167 307.789 0.181
202312 0.166 306.746 0.181
202403 0.132 312.332 0.141
202406 0.178 314.175 0.189
202409 0.222 315.301 0.235
202412 0.222 315.605 0.235
202503 0.224 319.799 0.234
202506 0.215 322.561 0.223
202509 0.182 324.800 0.187
202512 0.174 324.054 0.179
202603 0.180 330.213 0.182
202606 0.201 333.952 0.201

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is AVITA Medical (ASX:AVH) Overvalued in 2026?

Based on GuruFocus' analysis, AVITA Medical stock appears to be undervalued. The current stock price of A$1.54 is trading 46.7% below its estimated GF Value™ of A$2.89. GuruFocus considers AVITA Medical to be Possible Value Trap.

Key valuation signals for ASX:AVH:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: A$2.89 vs. price of A$1.54 (46.7% below fair value)
  • GF Score™: 52/100 with 7 warning signs

No single metric tells the full story. See the ASX:AVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AVITA Medical Business Description

Address 28159 Avenue Stanford, Suite 220, Valencia, Santa Clarita, CA, USA, 91355
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
52GF Score

Get the complete analysis for ASX:AVH

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.54
Price
A$2.89
GF Value